ContextVision Again Redefines Image Enhancement for Ultrasound

Medical technology software company is driving advanced patient care with latest innovations in image enhancement

STOCKHOLM – May 27, 2020 – ContextVision, a medical technology software company specializing in image analysis and artificial intelligence, today announced the release of RiventTM, its seventh generation of image enhancement software for 2D ultrasound.

Rivent levels up image enhancement for ultrasound applications and takes processing capabilities to the next level through strong processing that retains a natural look without introducing artifacts. Drawing upon ContextVision’s industry-leading expertise, Rivent provides unprecedented image quality with efficient noise reduction, clear tissue differentiation, and improved, reliable black areas.

To meet varying user needs and preferences, Rivent offers immense flexibility and customization possibilities as well as adaptability around the development of ultrasound systems in different application areas. The image quality can be automatically optimized in both near- and far-field as well as for variations in resolution, e.g. line density.

“With Rivent, we can now offer much more powerful processing than before, for example well-defined borders and efficient noise reduction, enabling smooth, homogenous tissue with enhanced contrast resolution,” said Ann-Sofi Hoff, Portfolio Manager, ContextVision. “We’re very excited to bring this product to the market and help our ultrasound customers further advance patient care with the highest image quality available.”

“We are proud to continually be at the forefront of medical imaging innovation,” said Ola Lindblad, VP of Medical Imaging, ContextVision. “The development of Rivent is a direct response to the medical community’s growing need for advancements in ultrasound, and we’re looking forward to collaboratively improving patient care through superior image quality.” 

To learn more about ContextVision’s image enhancement software, visit


About ContextVision:
ContextVision is a medical technology software company specialized in image analysis and artificial intelligence. As the global market leader within image enhancement, we are a trusted partner to leading manufacturers of ultrasound, X-ray and MRI equipment around the world.
Our expertise is to develop powerful software products, based on proprietary technology and artificial intelligence for image-based applications. Our cutting-edge technology helps clinicians accurately interpret medical images, a crucial foundation for better diagnosis and treatment.
ContextVision is now entering the fast-growing digital pathology market. We are re-investing significantly in our product portfolio of decision support tools and we are dedicated to becoming a leading resource for pathologists to radically develop cancer diagnosis and improve patient care.
The company, established in 1983, is based in Sweden with local representation in the U.S., Japan, China and Korea. ContextVision is listed on the Oslo Stock Exchange under the ticker COV.